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The β-lactamase inhibitor, clavulanic acid is frequently used in combination with β-lactam
antibiotics to treat a wide spectrum of infectious diseases. Clavulanic acid prevents drug
resistance by pathogens against these β-lactam antibiotics by preventing the degradation
of the β-lactam ring, thus ensuring eradication of these harmful microorganisms
from the host. This systematic review provides an overview on the fermentation
conditions that affect the production of clavulanic acid in the firstly described producer,
Streptomyces clavuligerus. A thorough search was conducted using predefined terms in
several electronic databases (PubMed, Medline, ScienceDirect, EBSCO), from database
inception to June 30th 2015. Studies must involve wild-type Streptomyces clavuligerus,
and full texts needed to be available. A total of 29 eligible articles were identified. Based on
the literature, several factors were identified that could affect the production of clavulanic
acid in S. clavuligerus. The addition of glycerol or other vegetable oils (e.g., olive oil,
corn oil) could potentially affect clavulanic acid production. Furthermore, some amino
acids such as arginine and ornithine, could serve as potential precursors to increase
clavulanic acid yield. The comparison of different fermentation systems revealed that
fed-batch fermentation yields higher amounts of clavulanic acid as compared to batch
fermentation, probably due to the maintenance of substrates and constant monitoring of
certain entities (such as pH, oxygen availability, etc.). Overall, these findings provide vital
knowledge and insight that could assist media optimization and fermentation design for
clavulanic acid production in S. clavuligerus.
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INTRODUCTION
Microorganisms serve as attractive resources, owing to their
ability to synthesize structurally-diverse substances with various
bioactivities (Demain, 1999; Newman et al., 2000; Bérdy, 2005;
Demain and Sanchez, 2009). These microbial natural products
may be used as effective drug(s) or act as drug lead compounds
that could be further modified and developed for higher
efficacy. Within the Bacteria domain, actinomycetes showed
unprecedented ability to produce potentially novel, clinically
useful, secondary metabolites such as anticancer, antioxidants,
antivirals and antibacterials (Ara et al., 2014; Lee et al., 2014a,b;
Manivasagan et al., 2014; Azman et al., 2015; Ser et al., 2015a,b;
Tan et al., 2015). These filamentous bacteria produce around 8700
antibiotics, with the majority of them derived from members
of the Streptomyces genus (Bérdy, 2005; Demain and Sanchez,
2009; de Lima Procópio et al., 2012). As the largest antibiotic-
producing genus, Streptomyces species are capable of producing
different classes of antibiotics including aminoglycosides (e.g.,
streptomycin by S. griseus), macrolides (e.g., tylosin from S.
fradiae), and β-lactams (e.g., cephamycin and clavulanic acid by
S. clavuligerus) (Waksman et al., 1944; Brown et al., 1976; Reading
and Cole, 1977; Okamoto et al., 1982).
The β-lactam antibiotics are one of the most popular classes of
antibacterial agents, whose mechanism of action is via inhibition
of bacterial cell wall synthesis (Page, 2012). Soon after the
utilization of β-lactam antibiotics, a number of bacteria have
been found to exhibit resistance to this class of drugs. One
of the strategies deployed by this group of bacteria to survive
against β-lactam antibiotics is by the production of a β-lactam-
hydrolyzing enzyme – β-lactamase; which functions to neutralize
these antibiotics by cleaving the β-lactam ring (Wilke et al.,
2005; Toussaint and Gallagher, 2015). Thus, to overcome this
resistance, β-lactamase inhibitors are often used in conjunction
with β-lactam antibiotics as these compounds prevent the
degradation of these antibiotics and increase the efficacy of these
drugs (Saudagar et al., 2008).
Clavulanic acid was first purified as a novel β-lactamase
inhibitor from S. clavuligerus ATCC 27064, which was isolated
from South American soil in 1971 (Higgens and Kastner,
1971; Brown et al., 1976). This compound presents with a
nucleus similar to that of penicillin, with notable differences
such as lacking anacylamino side chain, containing oxygen in
place of sulfur, and having a β-hydroxyethylidine substituent
in the oxazolidine ring (Brown et al., 1976; Saudagar et al.,
2008). Clavulanic acid or clavulanate, is commercially used
along with amoxicillin (Augmentin) and this combination
has been listed as an important antibacterial agents in
the WHO list of essential medicines (2015) (Toussaint and
Gallagher, 2015). This compound was first recovered from
the fermentation process, which remains as one of the most
frequently used strategies to manufacture important drugs and
their intermediates for medicinal use. In order to facilitate the
higher production of valuable compound as such, advanced
fermentation technologies were subsequently developed, which
included fed-batch fermentation systems (Thiry and Cingolani,
2002; Schmidt, 2005).
At the same time, researchers began to look into the
biosynthesis pathway of clavulanic acid in an attempt to
maximize its production (Figure 1). These efforts then resulted
in the identification of two important precursors for clavulanic
acid—arginine (C5 precursor) and glutaraldehyde-3-phosphate
(C3 precursor) (Romero et al., 1986; Kanehisa and Goto, 2000;
Kanehisa et al., 2016). Apart from clavulanic acid, S. clavuligerus
is known to produce other clavams and cephamycin; as illustrated
in Figure 1. As S. clavuligerus is unable to assimilate glucose,
various compounds have been studied as C3 precursor candidates
to ensure proper formulation of fermentationmedia and improve
the yield of clavulanic acid (Aharonowitz and Demain, 1978;
Garcia-Dominguez et al., 1989; Pérez-Redondo et al., 2010).
Thus, this systematic review examined the effect of different
fermentation conditions on the production of clavulanic acid in
S. clavuligerus. Based on the available literature, our objective
was to describe how additional supplements in basal medium,
pH, as well as temperature affect the production of the β-
lactamase inhibitor in S. clavuligerus, which in turn could
assist and improve the development of fermentation media
and/or systems for the production of this valuable antibiotic,
clavulanic acid.
METHODS
This systematic review was carried out in accordance with
the preferred reporting items for systematic reviews and meta-
analyses (PRISMA) guidelines (Moher et al., 2009).
Database Search
Systematic searches were performed in the following databases:
PubMed, Medline, ScienceDirect, and EBSCO.MeSH terms were
“Streptomyces,” “clavuligerus” combined with “clavulanic acid” or
“clavulanate.” We included studies from database inception to
June 30th, 2015.
Study Selection and Data Extraction
Two reviewers (H-LS and JW-FL) independently screened
and evaluated all titles and abstracts retrieved from the
comprehensive search, based on the inclusion and exclusion
criteria. The bibliographies of relevant studies were checked for
additional publications. Full text of selected original articles were
then obtained and reviewed. Any disagreements between the
two reviewers were resolved by consensus. Studies providing
data of clavulanic acid production in Streptomyces clavuligerus
were included. Other inclusion criteria were: (1) studies must
involve wild-type Streptomyces clavuligerus; (2) studies must
describe fermentation conditions using batch and/or fed-
batch fermentation strategies; and (3) studies must report the
specific amount of clavulanic acid produced by Streptomyces
clavuligerus. Studies conducted using S. clavuligerus mutants,
studies conducted in organisms other than S. clavuligerus, and
studies reporting only specific production of clavulanic acid;
were excluded. We also excluded solid phase extraction studies,
immobilization studies, and all reviews, conference abstracts,
systematic reviews, meta-analyses, comments, and letters to the
editor. The following information was extracted independently
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FIGURE 1 | Biosynthesis pathways of clavulanic acid (Kanehisa and Goto, 2000; Lynch and Yang, 2004; Kanehisa et al., 2016).
by the two reviewers from each study (Table 1): (1) study and
year of publication, (2) fermentation type and volume, (3) oxygen
control and/or airflow control, (4) fermentation/production
media composition and pH, (5) addition of supplements (e.g.,
glycerol, starch, and vegetable oils), and (6) maximum clavulanic
acid produced. Any discrepancies were discussed between both
authors.
RESULTS
Literature Search
The search yielded a total of 627 articles, while an additional 11
articles were obtained from other sources (Figure 2). After the
removal of duplicate records, a total of 474 articles were accessed,
out of which 432 articles were excluded based on their titles
and abstracts. 42 full text articles were reviewed, out of which
29 studies were eligible for the qualitative analysis according
to the inclusion criteria (Table 1). The analysis was divided
into several categories based on the design of the experiments:
(a) utilization of glycerol or starch as sole carbon source, (b)
addition of glycerol and different oil in batch fermentation, (c)
amino acids as supplements in basal medium, (d) other factors
affecting clavulanic acid production in batch fermentation, and
(e) comparison between batch and fed-batch fermentations.
Utilization of Glycerol, Starch, or Sucrose as Sole
Carbon Source
Thakur et al. (1999) and Maranesi et al. (2005) described
that different media compositions resulted in different levels of
clavulanic acid production. When comparing between glycerol
and sucrose as a sole carbon source, Lee and Ho (1996) observed
no production of clavulanic acid in media added with glycerol,
but higher production of the compound in media with sucrose
(3.63mg/L). Similar findings were also reported by Ives and
Bushell (1997) where no production of clavulanic acid was
observed in glycerol-containing C-limited media. Meanwhile,
another study by Thakur et al. (1999) demonstrated that the
addition of dextrin or glycerol as a sole carbon source neither
improved nor decreased the production of clavulanic acid. On the
contrary, two studies reported a totally different observation—
basal media containing glycerol exhibited higher maximum
amounts of clavulanic acid as compared to starch (Saudagar
and Singhal, 2007a; Bellão et al., 2013). Indeed the maximum
amount of clavulanic acid observed in media containing glycerol
Frontiers in Microbiology | www.frontiersin.org 3 April 2016 | Volume 7 | Article 522
Ser et al. Clavulanic Acid from Streptomyces clavuligerus
T
A
B
L
E
1
|
E
ff
e
c
t
o
f
fe
rm
e
n
ta
ti
o
n
c
o
n
d
it
io
n
s
o
n
c
la
v
u
la
n
ic
a
c
id
p
ro
d
u
c
ti
o
n
in
S
tr
e
p
to
m
y
c
e
s
c
la
v
u
li
g
e
ru
s
(M
a
x
C
A
,
m
a
x
im
u
m
c
la
v
u
la
n
ic
a
c
id
;
N
B
D
,
n
e
u
tr
a
li
z
e
d
,
b
le
a
c
h
e
d
a
n
d
d
e
o
d
o
ri
z
e
d
;
N
B
,
n
e
u
tr
a
li
z
e
d
a
n
d
b
le
a
c
h
e
d
;
T
N
,
to
ta
l
n
it
ro
g
e
n
;
N
.A
.,
n
o
t
a
v
a
il
a
b
le
).
R
e
fe
re
n
c
e
s
S
tr
a
in
B
a
s
a
l
m
e
d
iu
m
F
e
rm
e
n
ta
ti
o
n
ty
p
e
F
e
rm
e
n
te
r
v
o
lu
m
e
,
m
L
F
e
rm
e
n
ta
ti
o
n
v
o
lu
m
e
,
m
L
O
2
c
o
n
tr
o
l
p
H
T
e
m
p
e
ra
tu
re
,
◦
C
S
h
a
k
in
g
/S
ti
rr
e
r
s
p
e
e
d
,
rp
m
S
u
p
p
le
m
e
n
t
M
a
x
C
A
c
o
n
c
e
n
tr
a
ti
o
n
#
,
m
g
/L
F
ix
e
d
G
ra
d
ie
n
t
1
R
o
m
e
ro
e
t
a
l.,
1
9
8
6
N
R
R
L
3
5
8
5
G
ly
c
e
ro
l,
su
c
ro
se
,
p
ro
lin
e
,
N
a
C
l,
K
2
H
P
O
4
,
C
a
C
l 2
,
M
n
C
l 2
.4
H
2
O
,
F
e
C
l 3
.6
H
2
O
,
Z
n
C
l 2
,
M
g
S
O
4
.7
H
2
O
B
a
tc
h
N
.A
.
N
.A
.
N
o
7
N
.A
.
N
.A
.
N
.A
.
A
rg
in
in
e
O
rn
ith
in
e
1
6
µ
g
/m
g
D
W
*
9
µ
g
/m
g
D
W
*
2
L
e
b
ri
h
ie
t
a
l.,
1
9
8
7
N
.A
.
G
ly
c
e
ro
l,
L
-a
sp
a
ra
g
in
e
,
M
g
S
O
4
,
K
2
H
P
O
4
,
F
e
S
O
4
.7
H
2
O
,
M
n
C
l 2
.4
H
2
O
,
Z
n
S
O
4
.7
H
2
O
,
C
a
C
l 2
B
a
tc
h
1
0
0
0
/3
0
0
0
2
0
0
/6
0
0
N
o
6
.9
2
8
–
2
5
0
P
h
o
sp
h
a
te
(2
m
M
)
P
h
o
sp
h
a
te
(7
5
m
M
)
9
0 3
3
B
e
lm
a
r-
B
e
in
y
a
n
d
T
h
o
m
a
s,
1
9
9
1
N
.A
.
G
ly
c
e
ro
l,
m
a
lt
e
xt
ra
c
t,
b
a
c
te
ri
o
lo
g
ic
a
lp
e
p
to
n
e
,
p
o
ly
p
ro
p
yl
e
n
e
g
ly
c
o
l
(a
n
tif
o
a
m
)
B
a
tc
h
7
0
0
0
5
0
0
0
0
.5
vv
m
7
2
6
–
4
9
0
9
9
0
1
3
0
0
– – –
1
7
5
1
8
0
2
5
0
4
L
e
e
a
n
d
H
o
,
1
9
9
6
N
R
R
L
3
5
8
5
P
ro
lin
e
,
g
lu
ta
m
ic
a
c
id
,
N
a
C
l,
K
2
H
P
O
4
,
C
a
C
l 2
,
M
n
C
l 2
.4
H
2
O
,
F
e
C
l 3
.6
H
2
O
,
A
n
C
l 2
,
M
g
S
O
4
.7
H
2
O
B
a
tc
h
N
.A
.
4
0
N
o
8
.3
2
7
–
2
2
0
G
ly
c
e
ro
l
0
8
.3
S
u
c
ro
se
3
.6
3
9
.1
C
ru
d
e
p
a
lm
o
il
1
.2
6
8
.6
N
B
D
p
a
lm
o
le
in
0
.8
8
.5
N
B
D
p
a
lm
st
e
a
ri
n
0
.4
8
.0
N
B
p
a
lm
-k
e
rn
e
lo
le
in
1
.8
9
6
.5
N
B
p
a
lm
-k
e
rn
e
l
st
e
a
ri
n
2
.9
9
6
.4
O
le
ic
a
c
id
0
7
P
a
lm
iti
c
a
c
id
0
.6
4
7
.1
S
te
a
ri
c
a
c
id
1
.6
8
5
.7
8
L
a
u
ri
c
a
c
id
0
.0
8
5
Iv
e
s
a
n
d
B
u
sh
e
ll,
1
9
9
7
N
R
R
L
3
5
8
5
G
ly
c
e
ro
l,
N
H
4
C
l,
K
2
H
P
O
4
,K
H
2
P
O
4
,
M
g
S
O
4
.7
H
2
O
,
F
e
S
O
4
.7
H
2
O
C
u
C
l 2
,
C
o
C
l 2
,
C
a
C
l 2
.2
H
2
O
,
Z
n
C
l 2
,
M
n
C
l 2
,
N
a
2
M
o
O
4
B
a
tc
h
N
.A
.
1
5
0
0
N
.A
.
N
.A
.
3
0
–
7
5
0
C
-l
im
ite
d
(g
ly
c
e
ro
l,
1
5
g
/L
)
0
N
-l
im
ite
d
(N
H
4
C
l,
1
.5
g
/L
)
3
4
P
-l
im
ite
d
(N
o
K
2
H
P
O
4
,
re
p
la
c
e
d
w
ith
M
O
P
S
a
t
2
1
g
/L
)
3
5
6
K
w
o
n
a
n
d
K
im
,
1
9
9
8
A
T
C
C
2
7
0
6
4
S
ta
rc
h
-a
sp
a
ra
g
in
e
m
e
d
iu
m
B
a
tc
h
5
0
2
0
N
o
7
2
7
–
2
5
0
–
3
9
.8
3
-4
9
.7
9
M
e
th
yl
vi
o
lo
g
e
n
(a
d
d
e
d
a
ft
e
r
3
8
h
)
9
.9
6
-2
5
.8
9
(C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 4 April 2016 | Volume 7 | Article 522
Ser et al. Clavulanic Acid from Streptomyces clavuligerus
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
R
e
fe
re
n
c
e
s
S
tr
a
in
B
a
s
a
l
m
e
d
iu
m
F
e
rm
e
n
ta
ti
o
n
ty
p
e
F
e
rm
e
n
te
r
v
o
lu
m
e
,
m
L
F
e
rm
e
n
ta
ti
o
n
v
o
lu
m
e
,
m
L
O
2
c
o
n
tr
o
l
p
H
T
e
m
p
e
ra
tu
re
,
◦
C
S
h
a
k
in
g
/S
ti
rr
e
r
s
p
e
e
d
,
rp
m
S
u
p
p
le
m
e
n
t
M
a
x
C
A
c
o
n
c
e
n
tr
a
ti
o
n
#
,
m
g
/L
F
ix
e
d
G
ra
d
ie
n
t
m
e
n
a
d
io
n
e
(a
d
d
e
d
a
ft
e
r
3
8
h
)
4
7
.8
0
-6
7
.7
1
p
lu
m
b
a
g
in
(a
d
d
e
d
a
ft
e
r
3
8
h
)
5
5
.7
6
-7
9
.6
6
p
h
e
n
a
zi
n
e
m
e
th
o
su
lfa
te
(a
d
d
e
d
a
ft
e
r
3
8
h
)
6
3
.7
3
-1
0
3
.5
6
H
2
O
2
(a
d
d
e
d
a
ft
e
r
3
8
h
)
5
1
.7
8
-6
9
.7
1
7
G
o
u
ve
ia
e
t
a
l.,
1
9
9
9
N
R
R
L
3
5
8
5
G
ly
c
e
ro
l,
su
c
ro
se
,
p
ro
lin
e
,
g
lu
ta
m
ic
a
c
id
B
a
tc
h
5
0
0
5
0
N
o
6
.5
2
8
–
2
5
0
–
4
1
G
ly
c
e
ro
l,
su
c
ro
se
,
p
ro
lin
e
,
a
rg
in
in
e
–
8
3
G
ly
c
e
ro
l,
p
e
p
to
n
e
,
K
2
H
P
O
4
,
so
y
m
e
a
l
–
4
7
2
G
ly
c
e
ro
l,
p
e
p
to
n
e
,
K
2
H
P
O
4
,
S
a
m
p
ro
so
y
9
0
N
B
–
9
2
0
8
T
h
a
k
u
r
e
t
a
l.,
1
9
9
9
N
R
R
L
3
5
8
5
Y
e
a
st
e
xt
ra
c
t,
m
a
lt
e
xt
ra
c
t,
p
e
p
to
n
e
,
g
ly
c
e
ro
l
B
a
tc
h
2
5
0
2
7
N
o
7
3
0
–
2
0
0
–
8
0
K
m
e
d
iu
m
–
1
0
0
D
e
xt
ri
n
,
so
ya
b
e
a
n
m
e
a
l,
c
a
se
in
h
yd
ro
ly
sa
te
,
F
e
S
O
4
–
9
0
G
ly
c
e
ro
l,
su
c
ro
se
,
p
ro
lin
e
,
g
lu
ta
m
ic
a
c
id
–
4
0
9
G
o
u
ve
ia
e
t
a
l.,
2
0
0
1
N
.A
.
G
ly
c
e
ro
l,
K
2
H
P
O
4
B
a
tc
h
5
0
0
5
5
N
o
6
.5
2
8
–
2
5
0
S
o
yb
e
a
n
p
ro
te
in
e
xt
ra
c
t
1
1
2
0
C
o
rn
st
e
e
p
liq
u
o
r,
so
yb
e
a
n
p
ro
te
in
e
xt
ra
c
t
4
9
0
Y
e
a
st
e
xt
ra
c
t,
so
yb
e
a
n
p
ro
te
in
e
xt
ra
c
t
7
0
0
B
a
c
te
ri
o
lo
g
ic
a
l
p
e
p
to
n
e
,
so
yb
e
a
n
p
ro
te
in
e
xt
ra
c
t
9
0
0
1
0
C
h
e
n
e
t
a
l.,
2
0
0
2
A
T
C
C
2
7
0
6
4
S
o
ym
e
a
le
xt
ra
c
t,
p
e
p
to
n
e
,
K
2
H
P
O
4
B
a
tc
h
N
.A
.
1
0
0
N
o
7
2
8
–
2
0
0
G
ly
c
e
ro
l(
1
0
g
/L
)
1
1
.3
6
G
ly
c
e
ro
l(
1
5
g
/L
)
1
1
.7
9
G
ly
c
e
ro
l(
2
0
g
/L
)
1
0
.9
3 (C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 5 April 2016 | Volume 7 | Article 522
Ser et al. Clavulanic Acid from Streptomyces clavuligerus
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
R
e
fe
re
n
c
e
s
S
tr
a
in
B
a
s
a
l
m
e
d
iu
m
F
e
rm
e
n
ta
ti
o
n
ty
p
e
F
e
rm
e
n
te
r
v
o
lu
m
e
,
m
L
F
e
rm
e
n
ta
ti
o
n
v
o
lu
m
e
,
m
L
O
2
c
o
n
tr
o
l
p
H
T
e
m
p
e
ra
tu
re
,
◦
C
S
h
a
k
in
g
/S
ti
rr
e
r
s
p
e
e
d
,
rp
m
S
u
p
p
le
m
e
n
t
M
a
x
C
A
c
o
n
c
e
n
tr
a
ti
o
n
#
,
m
g
/L
F
ix
e
d
G
ra
d
ie
n
t
G
ly
c
e
ro
l(
3
0
g
/L
)
4
.6
1
G
ly
c
e
ro
l(
4
0
g
/L
)
2
.8
9
F
e
d
-b
a
tc
h
N
.A
.
1
0
0
N
o
7
2
8
–
2
0
0
–
1
1
5
G
ly
c
e
ro
l(
a
d
d
e
d
u
p
to
8
4
h
,
e
ve
ry
1
2
h
)
2
3
0
G
ly
c
e
ro
l(
a
d
d
e
d
u
p
to
1
0
8
h
,
e
ve
ry
1
2
h
)
2
5
5
G
ly
c
e
ro
l(
a
d
d
e
d
u
p
to
1
3
2
h
,
e
ve
ry
1
2
h
)
2
7
0
S
o
ym
e
a
le
xt
ra
c
t,
p
e
p
to
n
e
,
K
2
H
P
O
4
B
a
tc
h
5
0
0
0
3
0
0
0
1
vv
m
7
2
8
–
5
0
0
–
2
3
0
F
e
d
-b
a
tc
h
5
0
0
0
2
0
0
0
1
vv
m
7
2
8
–
5
0
0
G
ly
c
e
ro
l(
a
d
d
e
d
u
p
to
1
0
8
h
,
e
ve
ry
h
o
u
r)
2
8
0
1
1
C
h
e
n
e
t
a
l.,
2
0
0
3
A
T
C
C
2
7
0
6
4
G
ly
c
e
ro
l,
so
y
m
e
a
le
xt
ra
c
t,
p
e
p
to
n
e
,
K
H
2
P
O
4
B
a
tc
h
5
0
0
1
1
0
N
o
7
N
.A
.
N
.A
.
N
.A
.
–
1
1
5
O
rn
ith
in
e
2
0
0
A
rg
in
in
e
1
0
0
O
rn
ith
in
e
a
n
d
a
rg
in
in
e
1
2
5
F
e
d
-b
a
tc
h
5
0
0
1
1
0
N
o
7
N
.A
.
N
.A
.
N
.A
.
–
1
0
0
O
rn
ith
in
e
(a
d
d
e
d
e
ve
ry
1
2
h
)
1
1
0
A
rg
in
in
e
(a
d
d
e
d
e
ve
ry
1
2
h
)
2
1
0
G
ly
c
e
ro
l
(a
d
d
e
d
e
ve
ry
1
2
h
)
3
0
0
G
ly
c
e
ro
la
n
d
a
rg
in
in
e
(a
d
d
e
d
e
ve
ry
1
2
h
)
1
3
0
G
ly
c
e
ro
la
n
d
o
rn
ith
in
e
(a
d
d
e
d
e
ve
ry
1
2
h
)
2
0
0
1
2
Ly
n
c
h
a
n
d
Y
a
n
g
,
2
0
0
4
N
.A
.
G
ly
c
e
ro
l,
M
g
S
O
.7
H
2
O
,
K
2
H
P
O
4
,
F
e
S
O
4
.7
H
2
O
,
M
n
C
l 2
.4
H
2
O
,
Z
n
S
O
4
.H
2
O
,
C
a
C
l 2
B
a
tc
h
2
0
0
0
2
0
0
1
vv
m
6
.9
3
0
–
7
0
0
L
-l
ys
in
e
(1
g
/L
)
0
L
-l
ys
in
e
(2
0
g
/L
)
2
7
L
-l
ys
in
e
(1
g
/L
),
d
e
g
ra
d
e
d
c
la
vu
la
n
ic
a
c
id
4
2
1
3
L
in
e
t
a
l.,
2
0
0
5
A
T
C
C
2
7
0
6
4
G
ly
c
e
ro
l,
so
y
m
e
a
le
xt
ra
c
t,
p
e
p
to
n
e
,
K
H
2
P
O
4
B
a
tc
h
5
0
0
1
1
0
N
o
7
2
8
–
2
0
0
–
9
0 (C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 6 April 2016 | Volume 7 | Article 522
Ser et al. Clavulanic Acid from Streptomyces clavuligerus
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
R
e
fe
re
n
c
e
s
S
tr
a
in
B
a
s
a
l
m
e
d
iu
m
F
e
rm
e
n
ta
ti
o
n
ty
p
e
F
e
rm
e
n
te
r
v
o
lu
m
e
,
m
L
F
e
rm
e
n
ta
ti
o
n
v
o
lu
m
e
,
m
L
O
2
c
o
n
tr
o
l
p
H
T
e
m
p
e
ra
tu
re
,
◦
C
S
h
a
k
in
g
/S
ti
rr
e
r
s
p
e
e
d
,
rp
m
S
u
p
p
le
m
e
n
t
M
a
x
C
A
c
o
n
c
e
n
tr
a
ti
o
n
#
,
m
g
/L
F
ix
e
d
G
ra
d
ie
n
t
5
0
0
(1
1
m
m
b
a
ffl
e
h
e
ig
h
t)
–
1
3
0
5
0
0
(1
6
m
m
b
a
ffl
e
h
e
ig
h
t)
–
1
8
0
1
4
M
a
ra
n
e
si
e
t
a
l.,
2
0
0
5
N
.A
.
D
e
xt
ri
n
,
so
yb
e
a
n
flo
u
r,
m
a
lt
e
xt
ra
c
t,
F
e
S
O
4
.7
H
2
O
,
M
O
P
S
b
u
ff
e
r
B
a
tc
h
3
0
0
0
5
0
0
N
o
7
2
8
–
2
5
0
–
2
0
0
G
ly
c
e
ro
lb
a
c
to
p
e
p
to
n
e
,
so
yb
e
a
n
flo
u
r,
M
O
P
S
b
u
ff
e
r
–
1
0
0
S
ta
rc
h
,
so
yb
e
a
n
flo
u
r,
so
yb
e
a
n
o
il,
m
a
lt
e
xt
ra
c
t,
K
2
H
P
O
4
,
M
O
P
S
b
u
ff
e
r,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
O
–
4
5
8
G
ly
c
e
ro
l,
so
yb
e
a
n
flo
u
r,
S
a
m
p
ro
so
y
9
0
N
B
,
m
a
lt
e
xt
ra
c
t,
K
2
H
P
O
4
,
M
O
P
S
b
u
ff
e
r,
M
n
C
l 2
.4
H
2
0
,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
0
,
C
a
C
l 2
–
1
7
0
S
o
yb
e
a
n
flo
u
r,
so
yb
e
a
n
o
il,
m
a
lt
e
xt
ra
c
t,
K
2
H
P
O
4
,
M
O
P
S
b
u
ff
e
r,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
O
–
4
7
8
so
yb
e
a
n
flo
u
r,
m
a
lt
e
xt
ra
c
t,
K
2
H
P
O
4
,
M
O
P
S
b
u
ff
e
r,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
O
B
a
tc
h
3
0
0
0
5
0
0
N
o
7
2
8
–
2
5
0
S
o
yb
e
a
n
o
il
(1
6
g
/L
)
4
2
0
S
o
yb
e
a
n
o
il
(2
3
g
/L
)
7
5
3
S
o
yb
e
a
n
o
il
(3
0
g
/L
)
7
2
2
C
o
rn
o
il
(2
3
g
/L
)
6
8
0
S
u
n
flo
w
e
r
o
il
(2
3
g
/L
)
6
6
0
1
5
N
e
to
e
t
a
l.,
2
0
0
5
A
T
C
C
2
7
0
6
4
G
ly
c
e
ro
l,
S
a
m
p
ro
so
y
9
0
N
B
,
m
a
lt
e
xt
ra
c
t,
K
2
H
P
O
4
,
M
g
S
O
4
.7
H
2
O
,
M
g
C
l 2
.4
H
2
O
,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
O
B
a
tc
h
N
.A
.
4
0
0
0
0
.5
vv
m
6
.8
2
8
–
8
0
0
–
1
9
4 (C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 7 April 2016 | Volume 7 | Article 522
Ser et al. Clavulanic Acid from Streptomyces clavuligerus
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
R
e
fe
re
n
c
e
s
S
tr
a
in
B
a
s
a
l
m
e
d
iu
m
F
e
rm
e
n
ta
ti
o
n
ty
p
e
F
e
rm
e
n
te
r
v
o
lu
m
e
,
m
L
F
e
rm
e
n
ta
ti
o
n
v
o
lu
m
e
,
m
L
O
2
c
o
n
tr
o
l
p
H
T
e
m
p
e
ra
tu
re
,
◦
C
S
h
a
k
in
g
/S
ti
rr
e
r
s
p
e
e
d
,
rp
m
S
u
p
p
le
m
e
n
t
M
a
x
C
A
c
o
n
c
e
n
tr
a
ti
o
n
#
,
m
g
/L
F
ix
e
d
G
ra
d
ie
n
t
F
e
d
-b
a
tc
h
N
.A
.
2
5
0
0
0
.5
vv
m
6
.8
2
8
–
8
0
0
S
a
m
e
c
o
m
p
o
si
tio
n
a
s
m
e
d
ia
w
ith
lo
w
e
r
g
ly
c
e
ro
l
c
o
n
c
e
n
tr
a
tio
n
(1
0
g
/L
)
4
0
4
1
6
R
o
sa
e
t
a
l.,
2
0
0
5
A
T
C
C
2
7
0
6
4
G
ly
c
e
ro
l,
sa
m
p
ro
so
y
9
0
N
B
,
m
a
lt
e
xt
ra
c
t,
ye
a
st
e
xt
ra
c
t,
K
2
H
P
O
4
,
M
g
S
O
4
.7
H
2
O
,
M
n
C
l 2
.4
H
2
O
,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
O
B
a
tc
h
N
.A
.
4
0
0
0
0
%
6
.8
±
0
.1
2
8
–
3
0
0
–
0
1
2
%
6
0
0
–
2
5
4
2
1
%
8
0
0
–
4
7
5
2
8
%
1
0
0
0
–
6
1
4
4
3
%
8
0
0
–
4
8
2
5
0
%
2
5
0
-8
0
0
–
1
9
1
1
7
W
a
n
g
e
t
a
l.,
2
0
0
5
$
A
T
C
C
2
7
0
6
4
S
o
y
flo
u
r,
g
ly
c
e
ro
l,
o
rn
ith
in
e
,
K
2
H
P
O
4
,
F
e
S
O
4
,
M
g
S
O
4
B
a
tc
h
3
0
0
3
0
N
o
N
.A
.
2
8
–
2
5
0
V
a
ri
e
d
c
o
n
c
e
n
tr
a
tio
n
o
f
e
a
c
h
c
o
m
p
o
n
e
n
ts
2
1
7
–
5
2
6
1
8
B
u
sh
e
ll
e
t
a
l.,
2
0
0
6
N
R
R
L
3
5
8
5
G
ly
c
e
ro
l,
N
H
4
C
l,
K
2
H
P
O
4
,
M
O
P
S
,
M
g
S
O
4
.7
H
2
O
,
F
e
S
O
4
.7
H
2
O
,
C
u
C
l 2
,
C
o
C
l,
C
a
C
l 2
.2
H
2
O
,
Z
n
C
l 2
,M
n
C
l 2
,
N
a
2
M
o
O
4
B
a
tc
h
2
5
0
0
1
0
0
0
2
vv
m
6
.8
±
0
.2
3
0
–
7
5
0
–
9
4
1
9
Te
o
d
o
ro
e
t
a
l.,
2
0
0
6
A
T
C
C
2
7
0
6
4
G
ly
c
e
ro
l,
b
a
c
to
p
e
p
to
n
e
,
m
a
lt
e
xt
ra
c
t,
ye
a
st
e
xt
ra
c
t,
K
2
H
P
O
4
,
M
g
C
l 2
.4
H
2
O
,
M
n
C
l 2
.4
H
2
O
,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
O
,
si
lic
o
n
e
a
n
tif
o
a
m
B
a
tc
h
4
0
0
0
4
0
0
0
0
.5
vv
m
6
.8
±
0
.1
2
8
–
8
0
0
S
a
m
p
ro
so
y
9
0
N
B
(1
0
g
/L
)
1
3
5
S
a
m
p
ro
so
y
9
0
N
B
(2
0
g
/L
)
3
8
0
S
a
m
p
ro
so
y
9
0
N
B
(3
0
g
/L
)
2
9
0
2
0
O
rt
iz
e
t
a
l.,
2
0
0
7
A
T
C
C
2
7
0
6
4
G
ly
c
e
ro
l,
so
yb
e
a
n
o
il
(S
O
),
K
2
H
P
O
4
,
M
n
C
l 2
.4
H
2
O
,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
O
B
a
tc
h
5
0
0
5
0
N
o
6
.8
2
8
–
2
5
0
S
o
yb
e
a
n
flo
u
r
6
9
8
S
o
y
p
ro
te
in
is
o
la
te
3
3
8
B
a
tc
h
N
.A
.
4
0
0
0
N
o
6
.8
±
0
.1
2
8
–
8
0
0
S
o
yb
e
a
n
flo
u
r
(T
N
:
1
.6
g
/L
,
S
O
:
1
6
g
/L
)
7
4
2 (C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 8 April 2016 | Volume 7 | Article 522
Ser et al. Clavulanic Acid from Streptomyces clavuligerus
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
R
e
fe
re
n
c
e
s
S
tr
a
in
B
a
s
a
l
m
e
d
iu
m
F
e
rm
e
n
ta
ti
o
n
ty
p
e
F
e
rm
e
n
te
r
v
o
lu
m
e
,
m
L
F
e
rm
e
n
ta
ti
o
n
v
o
lu
m
e
,
m
L
O
2
c
o
n
tr
o
l
p
H
T
e
m
p
e
ra
tu
re
,
◦
C
S
h
a
k
in
g
/S
ti
rr
e
r
s
p
e
e
d
,
rp
m
S
u
p
p
le
m
e
n
t
M
a
x
C
A
c
o
n
c
e
n
tr
a
ti
o
n
#
,
m
g
/L
F
ix
e
d
G
ra
d
ie
n
t
S
o
yb
e
a
n
flo
u
r
(T
N
:
2
.4
g
/L
,
S
O
:
1
6
g
/L
)
8
4
0
S
o
yb
e
a
n
flo
u
r
(T
N
:
3
.2
/L
,
S
O
:
1
6
g
/L
)
9
0
6
S
o
yb
e
a
n
flo
u
r
(T
N
:
1
.6
g
/L
,
S
O
:
2
3
g
/L
)
6
6
0
S
o
yb
e
a
n
flo
u
r
(T
N
:
2
.4
g
/L
,
S
O
:
2
3
g
/L
)
6
7
0
S
o
yb
e
a
n
flo
u
r
(T
N
:
3
.2
g
/L
,
S
O
:
2
3
g
/L
)
7
9
6
2
1
S
a
u
d
a
g
a
r
a
n
d
S
in
g
h
a
l,
2
0
0
7
a
$
M
T
C
C
1
1
4
2
S
o
yb
e
a
n
flo
u
r,
d
e
xt
ri
n
,
p
e
p
to
n
e
,
K
H
2
P
O
4
B
a
tc
h
N
.A
.
N
.A
.
N
o
7
.0
±
0
.2
2
5
–
2
0
0
G
lu
c
o
se
5
2
.5
–
7
5
S
u
c
ro
se
3
7
–
5
2
.5
M
o
d
ifi
e
d
st
a
rc
h
8
7
.5
–
1
1
5
S
o
yb
e
a
n
o
il
1
0
7
.5
–
1
3
9
P
a
lm
o
il
6
0
–
1
3
9
G
ly
c
e
ro
l
9
7
.5
–
1
1
1
.5
S
o
yb
e
a
n
flo
u
r,
d
e
xt
ri
n
,
ri
c
e
b
ra
n
o
il,
K
H
2
P
O
4
B
a
tc
h
N
.A
.
N
.A
.
N
o
7
.0
±
0
.2
2
5
–
2
0
0
Y
e
a
st
e
xt
ra
c
t
9
2
.5
–
1
1
2
A
m
m
o
n
iu
m
c
a
rb
o
n
a
te
5
9
.5
–
9
5
A
m
m
o
n
iu
m
c
h
lo
ri
d
e
8
2
.5
–
9
6
S
o
d
iu
m
n
itr
a
te
1
7
.5
–
2
5
P
o
ta
ss
iu
m
n
itr
a
te
1
7
–
2
0
S
o
yb
e
a
n
flo
u
r,
so
yb
e
a
n
o
il,
d
e
xt
ri
n
,
ye
a
st
e
xt
ra
c
t,
K
2
H
P
O
4
B
a
tc
h
N
.A
.
N
.A
.
N
o
7
.0
±
0
.2
2
5
–
2
0
0
P
yr
u
vi
c
a
c
id
4
7
5
–
1
0
2
5
α
-k
e
to
g
lu
ta
ra
te
4
7
5
–
4
8
0
L
-l
e
u
c
in
e
4
7
5
–
1
1
7
5
L
-o
rn
ith
in
e
3
8
0
–
5
8
0
L
-p
ro
lin
e
4
7
5
–
1
1
2
5
L
-a
rg
in
in
e
5
1
0
–
1
4
0
0
L
-v
a
lin
e
2
7
5
–
5
0
0
B
a
tc
h
N
.A
.
N
.A
.
N
o
5
.0
2
5
–
2
0
0
–
3
0
5
5
.5
–
3
1
0
6
.0
–
4
6
0
6
.5
–
4
7
5
7
.0
–
4
9
0
7
.5
–
4
9
5
8
.0
–
3
0
0
8
.5
–
2
0
0 (C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 9 April 2016 | Volume 7 | Article 522
Ser et al. Clavulanic Acid from Streptomyces clavuligerus
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
R
e
fe
re
n
c
e
s
S
tr
a
in
B
a
s
a
l
m
e
d
iu
m
F
e
rm
e
n
ta
ti
o
n
ty
p
e
F
e
rm
e
n
te
r
v
o
lu
m
e
,
m
L
F
e
rm
e
n
ta
ti
o
n
v
o
lu
m
e
,
m
L
O
2
c
o
n
tr
o
l
p
H
T
e
m
p
e
ra
tu
re
,
◦
C
S
h
a
k
in
g
/S
ti
rr
e
r
s
p
e
e
d
,
rp
m
S
u
p
p
le
m
e
n
t
M
a
x
C
A
c
o
n
c
e
n
tr
a
ti
o
n
#
,
m
g
/L
F
ix
e
d
G
ra
d
ie
n
t
2
2
S
a
u
d
a
g
a
r
a
n
d
S
in
g
h
a
l,
2
0
0
7
b
A
T
C
C
2
7
0
6
4
G
ly
c
e
ro
l,
su
c
ro
se
,
p
ro
lin
e
,
g
lu
ta
m
ic
a
c
id
,
C
a
C
l 2
.2
H
2
O
,
F
e
C
l 3
,
M
n
C
l 2
,
N
a
C
l,
M
g
S
O
4
.7
H
2
O
,
Z
n
C
l 2
,
K
H
2
P
O
4
B
a
tc
h
N
.A
.
N
.A
.
N
.A
.
7
.0
±
0
.2
N
.A
.
–
N
.A
.
L
-a
rg
in
in
e
(1
–
1
0
0
m
M
)
6
0
0
-1
1
0
0
L
-p
ro
lin
e
(1
–
1
0
0
m
M
)
6
5
0
-8
5
0
L
-o
rn
ith
in
e
(1
–
1
0
0
m
M
)
6
5
0
–
7
5
0
L
-l
ys
in
e
(1
–
1
0
0
m
M
)
6
5
0
-9
0
0
L
-l
e
u
c
in
e
(1
–
1
0
0
m
M
)
3
0
-1
0
0
L
-g
lu
ta
m
in
e
(1
–
1
0
0
m
M
)
5
0
0
-8
0
0
L
-t
h
re
o
n
in
e
(1
–
1
0
0
m
M
)
7
5
0
-1
7
0
0
L
-t
ry
p
to
p
h
a
n
(1
–
1
0
0
m
M
)
6
0
0
-6
2
0
L
-c
ys
te
in
e
(1
–
1
0
0
m
M
)
4
2
0
-4
3
0
L
-v
a
lin
e
(1
–
1
0
0
m
M
)
2
0
-5
0
B
a
tc
h
N
.A
.
N
.A
.
N
.A
.
7
.0
±
0
.2
N
.A
.
N
.A
.
N
.A
.
K
H
2
P
O
4
(1
m
M
)
7
2
4
K
H
2
P
O
4
(1
0
m
M
)
8
7
8
K
H
2
P
O
4
(1
0
0
m
M
)
7
7
9
K
H
2
P
O
4
(2
0
0
m
M
)
5
2
4
F
e
d
-b
a
tc
h
N
.A
.
N
.A
.
N
.A
.
7
.0
±
0
.2
N
.A
.
N
.A
.
N
.A
.
C
o
n
tr
o
l
1
1
0
0
G
ly
c
e
ro
l(
a
d
d
e
d
e
ve
ry
1
2
h
til
l6
0
h
)
1
2
0
0
G
ly
c
e
ro
l(
a
d
d
e
d
e
ve
ry
1
2
h
til
l7
2
h
)
1
2
8
0
G
ly
c
e
ro
l(
a
d
d
e
d
e
ve
ry
1
2
h
til
l1
2
0
h
)
1
3
0
0
F
e
d
-b
a
tc
h
N
.A
.
N
.A
.
N
.A
.
7
.0
±
0
.2
N
.A
.
N
.A
.
N
.A
.
A
rg
in
in
e
(a
d
d
e
d
e
ve
ry
1
2
h
)
1
3
1
0
T
h
re
o
n
in
e
(a
d
d
e
d
e
ve
ry
1
2
h
)
1
8
6
3 (C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 10 April 2016 | Volume 7 | Article 522
Ser et al. Clavulanic Acid from Streptomyces clavuligerus
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
R
e
fe
re
n
c
e
s
S
tr
a
in
B
a
s
a
l
m
e
d
iu
m
F
e
rm
e
n
ta
ti
o
n
ty
p
e
F
e
rm
e
n
te
r
v
o
lu
m
e
,
m
L
F
e
rm
e
n
ta
ti
o
n
v
o
lu
m
e
,
m
L
O
2
c
o
n
tr
o
l
p
H
T
e
m
p
e
ra
tu
re
,
◦
C
S
h
a
k
in
g
/S
ti
rr
e
r
s
p
e
e
d
,
rp
m
S
u
p
p
le
m
e
n
t
M
a
x
C
A
c
o
n
c
e
n
tr
a
ti
o
n
#
,
m
g
/L
F
ix
e
d
G
ra
d
ie
n
t
2
3
E
ft
h
im
io
u
e
t
a
l.,
2
0
0
8
A
T
C
C
2
7
0
6
4
N
H
4
C
l,
K
H
2
P
O
4
,
M
O
P
S
B
a
tc
h
N
.A
.
5
0
N
o
6
.8
N
.A
.
N
.A
.
N
.A
.
G
ly
c
e
ro
l
2
5
S
u
n
flo
w
e
r
o
il
1
8
S
o
yb
e
a
n
o
il
N
.A
.
F
la
xs
e
e
d
o
il
N
.A
.
R
a
p
e
se
e
d
o
il
N
.A
.
O
liv
e
o
il
4
7
B
a
tc
h
2
1
0
0
1
6
0
0
0
.2
3
L
/m
in
6
.8
3
0
–
8
0
0
G
ly
c
e
ro
l
5
5
O
liv
e
o
il
4
5
2
4
K
im
e
t
a
l.,
2
0
0
9
N
R
R
L
3
5
8
5
S
o
ya
flo
u
r,
p
h
o
sp
h
a
te
,
M
g
C
l 2
.4
H
2
O
,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
O
B
a
tc
h
7
0
0
0
4
5
0
0
N
o
7
.0
N
.A
.
N
.A
.
N
.A
.
O
liv
e
o
il
8
2
0
P
a
lm
o
il
7
0
0
C
o
rn
o
il
3
8
0
Tr
io
le
in
9
8
9
Tr
ip
a
lm
iti
n
4
1
0
Tr
ili
n
o
le
in
2
2
0
2
5
S
a
le
m
-B
e
rk
h
it
e
t
a
l.,
2
0
1
0
A
T
C
C
2
7
0
6
4
S
ta
rc
h
,
so
yb
e
a
n
flo
u
r,
p
h
o
sp
h
a
te
,
Z
n
S
O
4
.H
2
O
,
F
e
S
O
4
.7
H
2
O
,
M
n
C
l 2
.4
H
2
O
B
a
tc
h
5
0
0
5
0
N
o
7
.0
2
8
–
2
5
0
G
ly
c
e
ro
l
5
6
4
O
liv
e
o
il
1
1
2
0
C
o
tt
o
n
se
e
d
o
il
7
4
0
C
o
rn
o
il
9
1
1
C
a
st
o
r
o
il
3
0
0
C
o
c
o
n
u
t
o
il
3
8
0
P
a
lm
o
il
5
8
0
S
u
n
flo
w
e
r
o
il
6
0
0
L
in
se
e
d
o
il
7
0
0
B
a
tc
h
5
0
0
5
0
N
o
6
.0
2
8
–
2
5
0
G
ly
c
e
ro
l
2
5
7
.0
G
ly
c
e
ro
l
5
6
4
8
.0
G
ly
c
e
ro
l
3
0
0
6
.0
O
liv
e
o
il
1
1
7
7
.0
O
liv
e
o
il
1
1
2
0
8
.0
O
liv
e
o
il
5
0
0
2
6
Te
o
d
o
ro
e
t
a
l.,
2
0
1
0
A
T
C
C
2
7
0
6
1
G
ly
c
e
ro
l,
b
a
c
to
p
e
p
to
n
e
,
m
a
lt
e
xt
ra
c
t,
ye
a
st
e
xt
ra
c
t,
K
2
H
P
O
4
,
M
g
C
l 2
.4
H
2
O
,
M
n
C
l 2
.4
H
2
O
,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
O
,
si
lic
o
n
e
a
n
tif
o
a
m
,
so
yb
e
a
n
o
il
B
a
tc
h
5
0
0
0
4
0
0
0
0
.5
vv
m
6
.8
±
0
.1
2
8
–
8
0
0
–
5
0
9 (C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 11 April 2016 | Volume 7 | Article 522
Ser et al. Clavulanic Acid from Streptomyces clavuligerus
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
R
e
fe
re
n
c
e
s
S
tr
a
in
B
a
s
a
l
m
e
d
iu
m
F
e
rm
e
n
ta
ti
o
n
ty
p
e
F
e
rm
e
n
te
r
v
o
lu
m
e
,
m
L
F
e
rm
e
n
ta
ti
o
n
v
o
lu
m
e
,
m
L
O
2
c
o
n
tr
o
l
p
H
T
e
m
p
e
ra
tu
re
,
◦
C
S
h
a
k
in
g
/S
ti
rr
e
r
s
p
e
e
d
,
rp
m
S
u
p
p
le
m
e
n
t
M
a
x
C
A
c
o
n
c
e
n
tr
a
ti
o
n
#
,
m
g
/L
F
ix
e
d
G
ra
d
ie
n
t
O
rn
ith
in
e
(0
.6
6
g
/L
)
5
6
0
O
rn
ith
in
e
(0
.9
9
g
/L
)
4
8
0
O
rn
ith
in
e
(1
.3
2
g
/L
)
3
8
0
F
e
d
-b
a
tc
h
5
0
0
0
3
4
0
0
0
.5
vv
m
6
.8
±
0
.1
2
8
–
8
0
0
–
1
3
9
0
O
rn
ith
in
e
(3
.7
g
/L
)
1
4
0
5
O
rn
ith
in
e
(7
.4
g
/L
1
4
0
0
O
rn
ith
in
e
(1
1
.1
g
/L
)
1
2
5
0
F
e
d
-b
a
tc
h
5
0
0
0
3
4
0
0
0
.5
vv
m
6
.8
±
0
.1
2
8
–
8
0
0
F
e
e
d
c
o
m
p
o
si
tio
n
sa
m
e
a
s
m
e
d
ia
1
0
5
0
G
ly
c
e
ro
l,
o
rn
ith
in
e
,
d
is
til
le
d
w
a
te
r
o
n
ly
1
0
8
0
F
e
d
-b
a
tc
h
5
0
0
0
3
4
0
0
0
.5
vv
m
6
.8
±
0
.1
2
8
–
8
0
0
G
ly
c
e
ro
l(
1
2
0
g
/L
)
1
0
5
0
G
ly
c
e
ro
l(
1
5
0
g
/L
)
1
2
0
0
G
ly
c
e
ro
l(
1
8
0
g
/L
)
1
5
0
6
G
ly
c
e
ro
l(
2
4
0
g
/L
)
1
1
2
5
F
e
d
-b
a
tc
h
1
0
0
0
0
8
0
0
0
0
.5
vv
m
6
.8
±
0
.1
2
8
–
8
0
0
O
rn
ith
in
e
(3
.7
g
/L
)
1
5
6
0
O
rn
ith
in
e
(5
.5
g
/L
)
1
5
0
0
2
7
C
e
rr
ia
n
d
B
a
d
in
o
,
2
0
1
2
N
.A
.
G
ly
c
e
ro
l,
b
a
c
to
p
e
p
to
n
e
,
K
2
H
P
O
4
,
M
g
S
O
4
.7
H
2
O
,
M
n
C
l 2
.4
H
2
O
,
F
e
S
O
4
.7
H
2
O
,
Z
n
S
O
4
.7
H
2
O
,
M
O
P
S
B
a
tc
h
N
.A
.
5
0
0
0
3
vv
m
6
.8
±
0
.1
N
.A
.
N
.A
.
–
–
4
5
4
4
.1
vv
m
–
–
2
6
9
B
a
tc
h
N
.A
.
4
0
0
0
N
o
6
.8
±
0
.1
N
.A
.
N
.A
.
6
0
0
–
2
6
9
8
0
0
–
4
0
2
2
8
C
o
st
a
a
n
d
B
a
d
in
o
,
2
0
1
2
A
T
C
C
2
7
0
6
4
G
ly
c
e
ro
l,
so
yb
e
a
n
p
ro
te
in
is
o
la
te
,
K
2
H
P
O
4
,
M
g
S
O
4
.7
H
2
O
,
M
O
P
S
B
a
tc
h
5
0
0
5
0
N
o
6
.8
2
0
–
2
5
0
–
1
2
6
6
.2
2
5
–
–
6
3
1
.6
3
0
–
–
1
6
8
.7
F
e
d
-b
a
tc
h
5
0
0
5
0
N
o
6
.8
2
0
–
2
5
0
G
ly
c
e
ro
l
(1
–
4
p
u
ls
e
s)
1
4
6
0
.0
-1
5
3
4
.3
2
5
1
0
5
1
.9
-1
1
8
6
.6
3
0
2
0
0
.0
-4
4
0
.1
2
9
B
e
llã
o
e
t
a
l.,
2
0
1
3
D
S
M
4
1
8
2
6
S
o
yb
e
a
n
m
e
a
l,
L
-l
ys
in
e
,
ye
a
st
e
xt
ra
c
t,
K
2
H
P
O
4
,
M
g
S
O
4
.7
H
2
O
,
C
a
C
l 2
.2
H
2
O
,
N
a
C
l,
F
e
S
O
4
.7
H
2
O
,
M
n
C
l 2
.4
H
2
O
,
Z
n
S
O
4
.7
H
2
O
B
a
tc
h
5
0
0
0
4
0
0
0
N
o
6
.8
±
0
.1
2
8
–
8
0
0
G
ly
c
e
ro
l
3
4
8
.5
S
ta
rc
h
1
2
5
.2
F
e
d
-b
a
tc
h
5
0
0
0
4
0
0
0
N
o
6
.8
±
0
.1
2
8
–
–
G
ly
c
e
ro
l
9
8
2
.1
S
ta
rc
h
4
6
9
.0
*T
h
e
s
tu
d
y
b
y
R
o
m
e
ro
e
t
a
l.
(1
9
8
6
)
e
xp
re
s
s
e
d
m
a
xi
m
u
m
c
la
vu
la
n
ic
a
c
id
p
ro
d
u
c
ti
o
n
in
a
d
iff
e
re
n
t
u
n
it
,
µ
g
o
f
c
la
vu
la
n
ic
a
c
id
p
e
r
m
g
o
f
b
io
m
a
s
s
d
ry
w
e
ig
h
t.
#
V
a
lu
e
s
e
s
ti
m
a
te
d
fr
o
m
o
ri
g
in
a
ls
tu
d
ie
s
.
$
F
o
r
m
e
d
ia
o
p
ti
m
iz
a
ti
o
n
,
s
tu
d
ie
s
u
s
e
d
fa
c
ti
o
n
a
lf
a
c
to
ri
a
ld
e
s
ig
n
m
a
tr
ix
( W
a
n
g
e
t
a
l.,
2
0
0
5
)
a
n
d
L
2
5
o
rt
h
o
g
o
n
a
la
rr
a
y
(S
a
u
d
a
g
a
r
a
n
d
S
in
g
h
a
l,
2
0
0
7
a
).
Frontiers in Microbiology | www.frontiersin.org 12 April 2016 | Volume 7 | Article 522
Ser et al. Clavulanic Acid from Streptomyces clavuligerus
FIGURE 2 | The PRISMA flow diagram showing the selection process of the studies included in the review.
was found to be 348.5 mg/L, nearly two times higher compared
to media with starch as a sole carbon source (Bellão et al.,
2013). Additionally, two other studies by Chen et al. (2002) and
Saudagar and Singhal (2007a) revealed a biphasic dose response
of glycerol; whereby clavulanic acid production was inhibited at
concentrations which were either too high or too low.
Addition of Glycerol and Different Oil in Batch
Fermentation
Apart from glycerol, several studies (n = 6) have also looked at
how other oil and unsaturated fatty acids affect the production
of clavulanic acid in S. clavuligerus. An earlier study revealed a
relatively low production of clavulanic acid in media containing
different fractions of palm oil or its purified, major constituents
(e.g., palmitic acid, stearic acid, lauric acid, oleic acid) (Lee and
Ho, 1996). A more recent study in 2009 by Kim et al. (2009)
reported maximum clavulanic acid production of 700mg/mL
in media supplemented with palm oil, an intermediate value
as compared to other oil sources. The highest clavulanic acid
production reported in the same study was observed in media
containing triolein (which is a major constituent of palm oil) at
989mg/L.
Different vegetable oils may stimulate the production of
clavulanic acid, as demonstrated by two different studies. In
batch fermentation, Efthimiou et al. (2008) described increased
clavulanic acid production when olive oil was used in place of
glycerol as a sole carbon source; with a maximum concentration
of 47mg/L being recorded, which is nearly double that observed
in media containing glycerol (25mg/L). These results were
consistent with another recent study, whereby the addition
of olive oil improved clavulanic acid production as compared
to glycerol; with a maximum concentration at 1120 and
564mg/L, respectively (Salem-Berkhit et al., 2010). Relatively
high production was also observed in media supplemented with
Frontiers in Microbiology | www.frontiersin.org 13 April 2016 | Volume 7 | Article 522
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corn oil (911mg/L), followed by cotton seed oil (740mg/L),
and linseed oil (700mg/L). Media with castor oil was found to
yield the lowest amount of clavulanic acid (300mg/L). Given
that different vegetable oils may have a slight difference in fatty
acids and lipid composition, Maranesi et al. (2005) described that
when the same concentration of oil was used, the production
of clavulanic acid differed slightly between soybean oil, corn
oil, and sunflower oil. The greatest concentrations of clavulanic
acid using soybean oil, corn oil, and sunflower oil was recorded
to be between the ranges of 660–753mg/L. These results were
consistent with a study by Saudagar and Singhal (2007a), as
similar concentrations of clavulanic acid was observed in media
containing palm oil and soybean oil.
Protein and Amino Acids as Supplements in Basal
Medium
The choice of soybean flour or soy protein isolate in fermentation
media affects the production of clavulanic acid by S. clavuligerus
(Gouveia et al., 1999; Wang et al., 2005; Ortiz et al., 2007).
The difference in the type of protein as a source of nitrogen
was found to affect the production of clavulanic acid as studied
by Gouveia et al. (2001). Increased production of clavulanic
acid was reported in media containing soybean flour (698mg/L)
rather than soy protein isolate (338mg/L). Further investigation
with soybean flour revealed that different amounts of nitrogen
with varied amounts of soybean oil, produced different
concentrations of clavulanic acid (660mg/L – 906mg/L). Similar
findings were reported by Teodoro et al. (2006) as different
clavulanic acid concentrations were observed (135–380mg/L)
in media containing varied concentrations of soy protein
isolate.
The investigation on the role of amino acids as a source of
nitrogen in the production of clavulanic acid began in 1986
(Romero et al., 1986). Several studies focusing on the effects of
the amino acids, arginine and ornithine; toward the production
of clavulanic acid showed inconsistent results. Romero et al.
(1986) reported maximum concentrations of clavulanic acid in
a slightly different manner, where 16µg/dry weight of biomass
was observed with arginine; while 9µg/dry weight of biomass
was observed with ornithine. Differing results were recorded
by Chen et al. (2003) as media supplemented with ornithine
contained higher concentrations of clavulanic acid at 200mg/L,
compared with arginine at 100mg/L. Nevertheless, recent studies
supported the results of Romero et al. (1986); where higher
amounts of clavulanic acid were seen in media supplemented
with different concentrations of arginine compared to ornithine
(Saudagar and Singhal, 2007a,b). One of the studies also
tested the effect of other amino acids such as L-proline, L-
lysine, L-leucine, L-glutamine, L-threonine, L-tryptophan, L-
cysteine, and L-valine (Saudagar and Singhal, 2007b). Among
these amino acids, the highest concentration of clavulanic
acid was observed in media supplemented with L-threonine;
which was not reported in other literature included in this
systematic review. Lynch and Yang (2004) tested the influence
of L-lysine further by adding degraded clavulanic acid into
the fermentation broth. The study suggested that L-lysine is
one of the most important amino acids for the production
of clavulanic acid, given that fermentation broths with low
concentrations of L-lysine (1 g/L) failed to yield any clavulanic
acid. Moreover, the addition of degraded clavulanic acid showed
improved clavulanic acid production (maximum clavulanic acid
concentration at 42mg/L) as compared to fermentation broths
with L-lysine alone (20 g/L, clavulanic acid concentration at
27mg/L).
Other Factors Affecting Clavulanic Acid Production in
Batch Fermentation
Aside from sole carbon or nitrogen sources, other factors
that may affect the production of clavulanic acid include the
addition of phosphate, pH, temperature, and agitation or shaking
speed. The potential repressive effect of phosphate on clavulanic
acid production in S. clavuligerus was demonstrated by two
selected studies (Lebrihi et al., 1987; Bushell et al., 2006;
Saudagar and Singhal, 2007b). The study by Lebrihi et al. (1987)
tested two levels of phosphate, 2 and 75mM. Based on HPLC
measurements, the lower concentration of phosphate (2mM) in
fermentation media was found to contain significantly higher
levels of clavulanic acid; with maximum concentration observed
at 90mg/L, as compared to 3mg/L observed in fermentation
media containing high concentrations of phosphate (75mM).
Without changing the pH of the media, Saudagar and Singhal
(2007b) demonstrated that the addition of phosphate in the
production medium showed a biphasic response. At the highest
tested concentration of KH2PO4 (200mM), the maximum
concentration of clavulanic acid dropped drastically to 524 mg/L.
Thus the optimum concentration of KH2PO4 for clavulanic acid
production was determined to be 10mM (with a maximum
clavulanic acid concentration recorded at 878mg/L).
Furthermore, the pH of fermentation media was described as
having a profound effect on clavulanic acid yield (Saudagar and
Singhal, 2007a; Salem-Berkhit et al., 2010). By using fermentation
media with different pH, different levels of clavulanic acid
were seen; with maximum concentrations reported at pH 7.
Similar patterns of clavulanic acid production were seen in the
tested fermentation media regardless of the sole carbon sources
used (i.e., glycerol or olive oil). In addition, Costa and Badino
(2012) reported that the temperature at which fermentation was
carried out may lead to variation in clavulanic acid production.
Low fermentation temperature (20◦C) resulted in maximum
clavulanic acid concentration as high as 1266.2mg/L as compared
to 631.6mg/L at 25◦C and 168.7mg/L at 30◦C.
Aeration or agitation speed throughout cultivation and
production was described to affect clavulanic acid yield as well.
In fact, the effect of aeration on the production of clavulanic acid
can be tested with a direct experiment involving the use of the
Erlenmeyer flask with different baﬄe heights (Lin et al., 2005).
The results showed that the flask with a higher baﬄe height had
a slight increase in the production of clavulanic acid (180 mg/L),
as compared to a normal Erlenmeyer flask (90mg/L). Another
study showed that agitation speed has a positive correlation with
clavulanic acid production (Rosa et al., 2005). At 800 rpm, two
flasks with different oxygen flow rates showed similar levels of
maximum clavulanic acid concentration, with 475mg/L obtained
from the flask with the lowoxygen flow rate and 482mg/L
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from the flask with the low oxygen flow rate. A study by Cerri
and Badino (2012) also supported the view that an increase in
agitation speed leads to higher production of clavulanic acid, but
not oxygen flow.When the oxygen flowwas increased to 4.1 vvm,
the maximum concentration of clavulanic acid was observed
to be 269mg/L, which is approximately half of the maximum
concentration observedwith an oxygen flow of 3 vvm (454mg/L).
However, these results were contradictory with a previous study
by Belmar-Beiny and Thomas (1991) which showed that there is
no significant difference in clavulanic acid production as a result
of different stirring speeds, even with same oxygen flow rate.
Besides that, the presence of redox-cycling agents in
the production media may influence the production of
clavulanic acid (Kwon and Kim, 1998). Five redox-cycling
agents were tested—methyl viologen, menadione, plubmagin,
phenazine methosulfate, and hydrogen peroxide (H2O2). All
of the redox-cycling agents promoted the production of
clavulanic acid, except methyl viologen (9.96–25.89mg/L). The
highest maximum clavulanic acid concentration was described
with phenazine methosulfate (63.73–103.56mg/L), followed by
plumbagin (55.76–79.66mg/L), and H2O2 (51.78–69.71mg/L).
Comparison between Batch and Fed-Batch
Fermentations
Among the selected studies, there were a total of seven fed-
batch fermentation experiments, with the majority looking at
the effect of adding glycerol into the fermenter over a period of
time. Most of the studies took similar approaches to study the
effect of glycerol in fed-batch fermentations: (a) by maintaining
glycerol at a certain level throughout the fermentation period
and/or (b) by adding fixed amounts of glycerol at fixed time
points (Chen et al., 2002; Neto et al., 2005; Saudagar and Singhal,
2007b; Teodoro et al., 2010; Costa and Badino, 2012). Regardless
of the methods, the study showed higher levels of maximum
clavulanic acid concentration than control in the fed-batch
fermentation. Comparing batch and fed-batch fermentation, fed-
batch fermentation systems seemed to generate a higher yield of
clavulanic acid (Chen et al., 2002; Neto et al., 2005; Bellão et al.,
2013). A study by Bellão et al. (2013) observed a highermaximum
clavulanic acid concentration in the latter method at 982.1mg/L,
as compared to 348.5mg/L. Apart from the addition of glycerol,
lower fermentation temperatures also resulted in a higher yield
of clavulanic acid, which was also observed in both batch and
fed-batch fermentation.
Besides that, the effects of amino acid was also studied
using the fed-batch fermentation approach. Following batch
fermentation that revealed increased clavulanic acid production
by arginine and threonine, Saudagar and Singhal (2007b)
showed that by using fed-batch fermentation technologies;
the production of the compound could be further increased.
Nevertheless, another study reported lower clavulanic acid yield
in fed-batch fermentation with the addition of ornithine as
compared to batch fermentation (Chen et al., 2003). On top
of that, an increase in the amount of clavulanic acid produced
was seen in other fed-batch experiments with the addition
of glycerol and arginine. Chen et al. (2003) reported that
fed-batch fermentation using glycerol, ornithine, and arginine;
yielded different amounts of clavulanic acid, whereby the highest
amount was demonstrated with glycerol (300mg/L), followed by
arginine (210mg/L), and the lowest with ornithine (110mg/L).
The addition of glycerol together with either of the amino
acids resulted in intermediate values, where the combination
of glycerol and arginine produced 130mg/L; while glycerol
and ornithine resulted in 200mg/L. Meanwhile, Teodoro et al.
(2010) investigated the influence of the presence of ornithine
in batch and fed-batch fermentation systems on clavulanic acid
production. The study did not find any significant changes in
maximum clavulanic acid production due to ornithine, regardless
of batch or fed-batch fermentation systems. Interestingly, the
same study also revealed an insignificant difference in maximum
clavulanic acid concentration when the feeding media (which
possesses the same composition as the production media)
was replaced with distilled water containing only glycerol and
ornithine (at same concentrations as the production media).
DISCUSSION
Themicrobial fermentation system is important for the discovery
and development of pharmaceutical drugs. Clavulanic acid as a
β-lactamase inhibitor was initially isolated from S. clavuligerus
ATCC 27064 using the traditional fermentation system (Higgens
and Kastner, 1971; Brown et al., 1976). β-lactamase inhibitors
help to prevent drug resistance against β-lactam antibiotics, and
allows successful eradication of harmful pathogens. Considering
its therapeutic value against infectious diseases, the biosynthesis
pathways of clavulanic acid in S. clavuligerus have been studied
extensively over the years; beginning around 1980s by a
research group led by Romero et al. (1986) (Figure 1). The
two precursors involved in clavulanic acid biosynthesis, arginine
and glyceraldehyde-3-phosphate; undergo a series of enzymatic
processes to form the β-lactam inhibitor. Given that both
arginine and glyceraldehyde-3-phosphate play an important role
in primary metabolism, the production of clavulanic acid could
be improved by refining the composition of the fermentation
media (Kirk et al., 2000). It is also presumed that S. clavuligerus
produces higher amount of clavulanic acid when there is
adequate supply of these precursors. The wild type strain of
S. clavuligerus is unable to metabolize glucose, and further
molecular studies revealed that the strain lacks the expression
of the glucose permease gene (Garcia-Dominguez et al., 1989;
Pérez-Redondo et al., 2010).
Based on literature obtained in this study, glycerol was found
to be the most popular choice of carbon source in clavulanic
acid production; in order to ensure an efficient supply of
glyceraldehyde-3-phosphate Once glycerol is metabolized into
glyceraldehyde-3-phosphate, it can either enter the clavulanic
acid biosynthesis pathway, or be involved in glycolytic or
gluconeogenesis reactions (Figure 3). The inclusion of glycerol
enhances the production of clavulanic acid as compared to
carbohydrates, as glycerol provides a higher energy content on a
weight-by weight basis (Efthimiou et al., 2008). As glycerol serves
as a backbone for triglycerides, its utilization by S. clavuligerus
has prompted researchers to study the potential of other oils
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FIGURE 3 | Important pathways that could affect metabolic pool of clavulanic acid precursors - arginine and glutaraldehyde-3-phosphate (Kirk et al.,
2000; Bushell et al., 2006).
to be used as a source of carbon. Vegetable oils such as olive
oil and corn oil may serve as cost-effective options as they
are readily available at a lower cost compared to carbohydrate
substrates. As compared to glycerol, vegetable oils seem to be a
more attractive source of energy; as a typical oil contains about
2.4 times more energy than glycerol (Stowell, 1987). Other than
preventing carbon catabolite regulation, these oils could act as
an antifoam, preventing the formation of foam in the media
that may impede gas exchange and negatively affect bacteria
growth (Friberg et al., 1989; Görke and Stülke, 2008). Overall,
the utilization of vegetable oils might be a better choice for
clavulanic acid production in fermentation processes compared
to glycerol, as these natural oils may further enrich themedia with
the presence of various polyunsaturated fatty acids (e.g., oleic
acid, linoleic acid) (Park et al., 1994). As the addition of olive oil
has been shown to greatly improve clavulanic acid production,
further investigations on the effect of vegetable oils could suggest
the potential of these compounds to be exploited as a cheaper
alternative source of carbon in fermentation processes.
On the other hand, many studies have shown the potential
of arginine and ornithine as specific precursors for clavulanic
acid. These two amino acids are believed to be interconvertible
by the urea cycle via the enzymatic action of arginase (Figure 3).
Even though presence of the urea cycle in prokaryotes was once
considered unusual, several recent studies have reported arginase
activity in S. clavuligerus (Mendz and Hazell, 1996; Bushell
et al., 2006). These reports then further suggest an important
role of this pathway in clavulanic acid biosynthesis. Thus, the
addition of arginine or ornithine in fermentation media would
increase the flow of C5 precursors into the biosynthesis pathway,
which then subsequently increase the production of clavulanic
acid (Romero et al., 1986; Lynch and Yang, 2004). From the
included studies, one study showed that L-threonine improved
the production of clavulanic acid (Saudagar and Singhal, 2007b).
Indeed the supplementation of L-threonine was found to prevent
the anaplerotic flux on pyruvate to synthesize amino acids such
as isoleucine, which in turn increased the availability of C3
precursors and eventually enhanced clavulanic acid production
(Ives and Bushell, 1997; Bushell et al., 2006; Saudagar and
Singhal, 2007b). Even though the study by Saudagar and Singhal
(2007b) has emphasized the role of L-threonine in clavulanic acid
production, arginine and ornithine have demonstrated relatively
strong influence on clavulanic acid production in S. clavuligerus.
Thus, further studies on L-threonine could eventually shed
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some light on the importance of this amino acid in clavulanic
acid production, particularly using the metabolic flux analysis
approach.
Apart from media composition, environmental stress is
known to affect the production of secondary metabolites in
microorganisms including members of Streptomyces genus. The
availability of oxygen determines the growth and survival of
the bacteria as well as production of secondary metabolites,
which includes antibiotics in S. clavuligerus (Yegneswaran
et al., 1991). Out of the selected studies, there were three
studies which highlighted the importance of oxygen control
and agitation speed. Fermentation in bioreactors is often paired
with computers for precise control of reaction conditions. Rosa
et al. (2005) showed that the high speed stirring promoted the
production of clavulanic acid, which was associated with a lower
amount of biomass production. It is believed that the high speed
stirring prevents cell clumping and also causes cell shearing
(Toma et al., 1991; Rosa et al., 2005). Additionally, Kwon and
Kim (1998) demonstrated that the addition of redox-cycling
agents increased clavulanic acid production. The presence of
reactive oxygen species in the fermentation media leads to an
imbalance in redox status, which could trigger stress and damage
microbials, or even lead to cell death (Cabiscol et al., 2010).
The breakage and/or damage of bacterial cells upon exposure to
such stress in turn, encourage the neighboring cells to produce
secondary metabolites in an attempt to survive and protect
against the challenge (Toma et al., 1991; Joshi et al., 1996; Rosa
et al., 2005).
In addition, temperature and pH control are also crucial for
the production of clavulanic acid and stability of the compound.
S. clavuligerus ATCC 27064 was reported to have optimal growth
from 26 to 30◦C with no growth above 37◦C (Higgens and
Kastner, 1971), while most of the selected studies reported that
fermentation temperature ranged between 20 and 30◦C. Costa
and Badino (2012) demonstrated a maximum clavulanic acid
concentration of 1266.2 mg/L when fermentation was performed
at 20◦C. The study also mentioned that lower concentrations of
clavulanic acid was observed with the increase in fermentation
temperature. Even though a low temperature of 20◦C was not
favorable for the growth of S. clavuligerus, high production
yield of clavulanic acid was observed. There are two possible
explanations that could lead to this observation: (a) the low
temperature places “cold” stress upon the organismwhich in turn
promotes the production of secondary metabolites (including
clavulanic acid); (b) the low temperature may have lowered
degradation rate of clavulanic acid, thus ensuring the stability
of the compound (Beales, 2004; Bersanetti et al., 2005; Jerzsele
and Nagy, 2009; Santos et al., 2009; Feng et al., 2011). Similarly,
pH of the medium could affect the growth of S. clavuligerus,
as it is described to grow between pH 5.0 and 8.5, however
sporulation is not observed from pH 7.0 to 8.5 (Higgens
and Kastner, 1971). Hence, the determination of the optimum
temperature and pH for the fermentation process is critical as
slight changes in these factors could tip off the balance between
the growth of the organism (biomass) and the production of
secondary metabolite(s). On top of that, clavulanic acid was
shown to be more stable at a neutral pH, as the decomposition
rate was described to be higher at acidic or alkaline pH
(Jerzsele and Nagy, 2009). Taken altogether, the pH of the
media and fermentation temperature may play important roles in
clavulanic acid production as these factors could eventually lead
to degradation of this valuable compound.
In this review, most of the selected papers used a one-
factor-at-a-time method in batch fermentation to study the
effect of carbon or nitrogen sources on clavulanic production
in S. clavuligerus. However, two studies incorporated more
complicated analyses in their studies to facilitate multifactorial
comparisons. For instance, Wang et al. (2005) proposed using
statistical methods to optimize the fermentation media for
clavulanic acid production by S. clavuligerus. By combining
factional factorial design and response surface methodology,
the study suggested optimal concentration of three of the most
important components identified via factional factorial design—
soy meal powder (38.102 g/L), FeSO4.7H2O (0.395 g/L), and
ornithine (1.177 g/L). Meanwhile, Saudagar and Singhal (2007a)
designed a slightly different fermentation media by undertaking
another statistical approach to optimize fermentation media
for clavulanic acid production. By using the L25 orthogonal
array method, the study suggested optimum concentrations of
soybean flour (8.8%), soybean oil (1.2%), dextrin (1.0%), yeast
extract (1.5%), and KH2PO4 (0.2%); with an optimal pH of 7.0
± 0.2. Thus in designing a fermentation media for clavulanic
acid production, it is important to ensure that the media can
support the proper growth of S. clavuligerus; as well as provide
factors that could stimulate the production of valuable secondary
metabolites. Following media optimization, several studies have
also incorporated another strategy to maximize the production
of clavulanic acid—by utilizing fed-batch fermentation systems
which represent a high throughput platform as compared to
traditional batch fermentation methods.
The main difference between batch and fed-batch
fermentation systems is that the latter is frequently monitored
with the assistance of sophisticated technologies and allows
precise control of the entire fermentation process (Longobardi,
1994; Li et al., 2014). As a scale-up production process, the
fed-batch fermentation system often allows an increase in
productivity with a concomitant decrease in production cost.
At the time of writing, the current report is one of the first that
reviews and investigates the effects of fermentation conditions
affecting the production of clavulanic acid in S. clavuligerus;
and further compares the batch and fed-batch fermentation
systems for clavulanic acid production. Costa and Badino (2012)
and Bellão et al. (2013) reported the utilization of glycerol
in fed-batch fermentation systems resulted in a surge in the
production of clavulanic acid (observed as a 1.2–2.8-fold increase
in maximum clavulanic acid amount, depending on other factors
such as temperature). Compared to glycerol, the addition of
amino acid (as a source of nitrogen) in fed-batch fermentation
showed less of an effect on the production of clavulanic acid.
Only three studies reported the effect of amino acid in fed-batch
fermentation (Chen et al., 2003; Saudagar and Singhal, 2007b;
Teodoro et al., 2010); where one of the studies discovered
that the addition of arginine and ornithine did not affect the
production of clavulanic acid in both batch and fed-batch
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fermentation systems (Saudagar and Singhal, 2007b). Chen et al.
(2003) discovered that ornithine increased the production of
clavulanic acid in batch but not fed-batch fermentation, while
arginine increased the production in fed-batch but not batch
fermentation. Given that the fed-batch fermentation system
entails a scale-up process, researchers would expect a higher yield
of end-products (Modak et al., 1986; Thiry and Cingolani, 2002;
Hewitt and Nienow, 2007). However, it has been suggested that
sometimes a large-scale fed-batch fermentation may not generate
similar results as observed in small-scale batch fermentation,
as the fed-batch fermentation system involves a more dynamic
environment (Hewitt and Nienow, 2007). Nevertheless, fed-
batch fermentation appears to be a better fermentation strategy
for clavulanic acid production as demonstrated in the selected
studies. Likewise, further investigations using this fermentation
method could upscale clavulanic acid production and ensure
a better understanding of the biosynthesis pathways for this
valuable compound.
FUTURE PROSPECT AND CONCLUSION
Over a span of 30 years, the research on the fermentation process
for the production of clavulanic acid has gained remarkable
interest from the scientific community. In this systematic review,
a total of 29 studies was selected after a thorough literature search.
It is worth mentioning that there were some inconsistencies in
the measurement of clavulanic acid production in S. clavuligerus
as some studies did not report the standard deviation even
though the experiments were carried out in replicate. This then
did not allow for results to be synthesized quantitatively and
perform a meta-analysis. The majority of the articles highlighted
the importance of media composition and supplements in the
production of clavulanic acid, particularly glycerol, vegetable
oils, and the amino acids, arginine and ornithine. In batch
fermentation systems which are commonly used for laboratory-
scale production, the utilization of various sugars (e.g., dextrin
and sucrose) and glycerol as sole carbon sources in clavulanic acid
production requires further investigation; as current studies have
reported inconsistent results and the role of these compounds
in the biosynthesis pathways is yet to be clearly defined.
Further investigation into the role of carbohydrates and glycerol
in clavulanic acid biosynthesis would greatly improve the
knowledge of media optimization. Nevertheless, the utilization
of different oil sources as a sole carbon source and amino
acids as a source of nitrogen in the fermentation media seems
to have a strong influence on clavulanic acid production in
S. clavuligerus; followed by other factors such as pH and
temperature. Among the vegetable oils, media supplemented
with olive oil showed the highest level of clavulanic acid
production, which indicates that olive oil contains potentially
important nutrients that could improve the production of the
antibiotics. Furthermore, amino acids such as arginine and
ornithine which could serve as C5 precursors, have also been
shown to increase clavulanic acid yield. For the most part, the
development of scale-up production tools such as fed-batch
fermentation systems could offer a “budget-friendly” method for
clavulanic acid production, as this is particularly important for
the pharmaceutical industry where production cost is one of
the major concerns. With the advancement of next generation
sequencing technologies, researchers have identified numerous
genes involved in clavulanic acid biosynthesis in S. clavuligerus
including the clavaminate synthases genes (Medema et al., 2011).
By combining this knowledge, further studies involve scale-up
productions would be beneficial to identify biosynthetic roles, as
well as determine the regulation of these carbon and nitrogen
sources in clavulanic acid production in S. clavuligerus.
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